Evidence map›Paper›PMID 33481135›Full record

ArticleJournal of bioenergetics and biomembranes2021

LINC00261 relieves the progression of sepsis-induced acute kidney injury by inhibiting NF-κB activation through targeting the miR-654-5p/SOCS3 axis.

Xinying Li, Jinying Li, Ping Lu, Mingzhe Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Non-Coding RNAs in Kidney Diseases: The Long and Short of Them.International journal of molecular sciences · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xinying Li *Department of Emergency, Shandong Otolaryngological Hospital Affiliated to Shandong University, No.4 DuanXing West Road, Huaiyin District, Jinan, 250022, Shandong Province, China.
Jinying Li *Department of Emergency, Shandong Otolaryngological Hospital Affiliated to Shandong University, No.4 DuanXing West Road, Huaiyin District, Jinan, 250022, Shandong Province, China.
Ping LuDepartment of Emergency, The Fourth People's Hospital of Jinan, Jinan, 250031, Shandong Province, China.
Mingzhe LiDepartment of Emergency, Shandong Otolaryngological Hospital Affiliated to Shandong University, No.4 DuanXing West Road, Huaiyin District, Jinan, 250022, Shandong Province, China. limingzhe1123@163.com.ORCID 0000-0002-6990-0723
Shandong University · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening disease, which can cause the dysfunction of multiple organs, including kidney. Recently, a number of studies found that the long non-coding RNA (lncRNA) is closely associated with the development and progression of sepsis; however, the role of long intergenic non-protein coding RNA 261 (LINC00261) in sepsis-induced acute kidney injury is poorly understood. In this study, we found the expression of LINC00261 was significantly decreased in the serum of patients with sepsis than healthy controls. A similar result was also observed in the mouse model of sepsis induced by lipopolysaccharide (LPS). Further investigations revealed that overexpression of LINC00261 improved the viability, suppressed the apoptosis and reduced the generation of inflammatory cytokines in LPS-treated HK-2 cells. Mechanistically, we confirmed that LINC00261 could function as a sponge to combine with microRNA-654-5p (miR-654-5p) which inhibits nuclear factor-κB (NF-κB) activity by targeting suppressor of cytokine signaling 3 (SOCS3). In conclusion, our results demonstrate that LINC00261 may regulate the progression of sepsis-induced acute kidney injury via the miR-654-5p/SOCS3/NF-κB pathway and therefore provides a new insight into the treatment of this disease.

Indexed as

Acute Kidney InjuryAnimalsCase-Control StudiesCell Line, TumorDisease Models, AnimalDisease ProgressionHEK293 CellsHumansMiceMicroRNAsNF-kappa BRNA, Long NoncodingSepsisSignal TransductionSuppressor of Cytokine Signaling 3 Proteinlong non-coding RNA 00261, humanMicroRNAsMIRN654 microRNA, humanNF-kappa BRNA, Long NoncodingSOCS3 protein, humanSocs3 protein, mouseSuppressor of Cytokine Signaling 3 ProteinAcute kidney injuryLINC00261miR-654-5pNF-κBSepsis

Identifiers

PMID33481135
OpenAlexW3123032097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.